• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » JSS Medical Research widens its global presence across Asia/Pacific region

JSS Medical Research widens its global presence across Asia/Pacific region

May 7, 2015
CenterWatch Staff

JSS Medical Research, a Montreal, Canada-based CRO, has acquired Max Neeman International (MNI), a full-service CRO based in New Delhi, India. Additional regional offices are located in Ahmedabad, Bangalore, Chennai and Mumbai. Through a U.S. subsidiary, a regional office also is located in North Carolina.

This global expansion in India follows the acquisition of Latam Clinical Trials, a CRO in Bogota, Colombia, that established the company's presence in Latin America.

"Our collaborations with MNI in recent years have enabled us to have first-hand evidence of the quality, integrity, credibility and client centric focus of this organization that is comparable to our philosophy," said Stella Boukas, chief operating officer of JSS Medical Research.

"This expansion enables us to provide our large pharmaceutical clients with our services to their regional affiliates in India and surrounding regions. For our biotech clients, the expansion will provide them with access to patients and high quality research sites that will facilitate the completion of their clinical development programs. This is an important step for JSS Medical Research in its evolution as a niche global CRO and a major achievement for the Canadian and Quebec Health Care Research Industry, because it is testimony to the fact that the quality and value of the scientific work done here transcends geographic borders and limits,” said Dr. John S. Sampalis, CEO of JSS Medical Research.

Dr. Toni Rinow, chief financial officer at JSS Medical Research, added that JSS continues on its global expansion strategy and is seeking to further strengthen its position in the US and in Europe supported by its financial partners.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing